| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'26 | $3.12 | - | - |
| Q1'27 | $3.25 | $3.88 | +19.4% |
| Q3'25 | $2.86 | $3.25 | +13.6% |
| Q2'25 | $2.78 | $2.91 | +4.7% |
| Q1'25 | $2.55 | $2.58 | +1.3% |
| Q4'24 | $2.61 | $2.78 | +6.4% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'26 | $11.1B | - | - |
| Q1'27 | $11.2B | $11.1B | -0.3% |
| Q3'25 | - | $10.3B | - |
| Q2'25 | - | $10.2B | - |
| Q1'25 | - | $9.8B | - |
| Q4'24 | - | $10.0B | - |
Market Data
CRM is currently trading at $163.11, giving Salesforce, Inc. a market cap of 135.90B and a P/E ratio of 16.9. Today's range spans $162.20–$166.30, with shares opening at $165.60 and moving down $0.22 (0.1%) from the prior close. DailyIQ's technical score sits at 50/100 (HOLD) with a news sentiment reading of 55/100.
Over the past year CRM has traded between $146.32 and $275.56 - the current price is +11.5% off the 52-week low and -40.8% from the high. 58 analysts cover the stock with a Buy consensus and a mean 12-month target of $245.60 (range $160.00–$475.00), implying upside of +50.6%.
Systematic models flag CRM as a hold in the current environment - large-cap, Technology, 135.90B market cap, 50/100 (HOLD), sentiment neutral at 55/100. Price: $163.11 (near 52-week lows). The current P/E ratio stands at 16.9. Quant strategies at this size tier typically shift allocation toward higher-momentum names during neutral phases, but maintain a base position given the structural liquidity that prevents disorderly exits. Annual range: $146.32–$275.56.
The 52-week range of $146.32–$275.56 for CRM provides the structural reference that options traders, systematic funds, and discretionary managers all anchor to — and at $163.11 (near 52-week lows), the stock sits in a zone where the next 5–10% move will likely define which crowd was right. A HOLD signal at 50/100 and neutral news backdrop (55/100) don't break the tie yet, but they narrow the probability distribution toward the upside.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).